Data Science in the News

Did you know we have a monthly newsletter? View past volumes and subscribe.

LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug

June 6, 2024 - 
In a substantial milestone for supercomputing-aided drug design, LLNL and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. The development of the new drug—BBO-8520—is the result of collaboration among LLNL, BridgeBio and the National Cancer...

The Laboratory’s habit of innovation

June 4, 2024 - 
LLNL’s HPC and data science capabilities play a significant role in international science research and innovation, and Lab researchers have won 10 R&D 100 Awards in the Software–Services category in the past decade. The latest issue of Science & Technology Review features several award-winning projects, including ZFP and CANDLE: (1) ZFP introduces a new method of compressing large data sets...

Statistical framework synchronizes medical study data

June 3, 2024 - 
The risks and benefits of heart surgery, chemotherapy, vaccination, and other medical treatments can change based on the time of day they are administered. These variations arise in part due to changes in gene expression levels throughout the 24-hour day-night cycle, with around 50% of genes displaying oscillatory behavior. To evaluate new therapies, investigators study how a gene’s...

GUIDE team develops approach to redesign antibodies against viral pandemics

May 8, 2024 - 
In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving LLNL researchers has successfully combined an AI-backed platform with supercomputing to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by viral evolution. The team’s research is published in the journal Nature and showcases a...

Welcome new DSI team members

April 2, 2024 - 
When Data Science Institute (DSI) director Brian Giera and deputy director Cindy Gonzales began planning activities for fiscal year 2024 and beyond, they immediately realized that LLNL’s growth in data science and artificial intelligence (AI)/machine learning (ML) research requires corresponding growth in the DSI’s efforts. “Our field is booming,” Giera states. “The Lab has a stake in the...

Machine learning tool fills in the blanks for satellite light curves

Feb. 13, 2024 - 
When viewed from Earth, objects in space are seen at a specific brightness, called apparent magnitude. Over time, ground-based telescopes can track a specific object’s change in brightness. This time-dependent magnitude variation is known as an object’s light curve, and can allow astronomers to infer the object’s size, shape, material, location, and more. Monitoring the light curve of...

Data Science Summer Institute hosts student interns from Japan

Oct. 13, 2023 - 
The Data Science Summer Institute (DSSI) hosted summer student interns from Japan on-site for the first time, where the students worked with Lab mentors on real-world projects in AI-assisted bio-surveillance and automated 3D printing. From June to September, the three students—Raiki Yoshimura, Shinnosuke Sawano and Taisei Saida—lived in rental apartments near the Lab and worked at the Lab on...

Making machine learning safer for biomedicine

Aug. 15, 2023 - 
It’s hard to understate the impact machine learning will have on biomedicine. The ability to train computers to spot patterns by analyzing large, complex datasets is driving discoveries in heart disease, cancer, neurodegenerative diseases and more. For instance, Argonne National Laboratory (ANL) has used machine learning to aid cancer research and accelerate COVID-19 antiviral discovery. One...

Consulting service infuses Lab projects with data science expertise

June 5, 2023 - 
A key advantage of LLNL’s culture of multidisciplinary teamwork is that domain scientists don’t need to be experts in everything. Physicists, chemists, biologists, materials engineers, climate scientists, computer scientists, and other researchers regularly work alongside specialists in other fields to tackle challenging problems. The rise of Big Data across the Lab has led to a demand for...

Celebrating the DSI’s first five years

May 18, 2023 - 
View the LLNL Flickr album Data Science Institute Turns Five. Data science—a field combining technical disciplines such as computer science, statistics, mathematics, software development, domain science, and more—has become a crucial part of how LLNL carries out its mission. Since the DSI’s founding in 2018, the Lab has seen tremendous growth in its data science community and has invested...

Scientists develop model for more efficient simulations of protein interactions linked to cancer

March 28, 2023 - 
LLNL scientists have developed a theoretical model for more efficient molecular-level simulations of cell membranes and their lipid-protein interactions, part of a multi-institutional effort to better understand the behavior of cancer-causing membrane proteins. Developed under an ongoing collaboration by the Department of Energy and the National Cancer Institute (NCI) aimed at modeling cell...

Understanding the universe with applied statistics (VIDEO)

Nov. 17, 2022 - 
In a new video posted to the Lab’s YouTube channel, statistician Amanda Muyskens describes MuyGPs, her team’s innovative and computationally efficient Gaussian Process hyperparameter estimation method for large data. The method has been applied to space-based image classification and released for open-source use in the Python package MuyGPyS. MuyGPs will help astronomers and astrophysicists...

LLNL cancer research goes exascale

July 20, 2022 - 
An LLNL team will be among the first researchers to perform work on the world’s first exascale supercomputer—Oak Ridge National Laboratory’s Frontier—when they use the system to model cancer-causing protein mutations. Led by Harsh Bhatia, a computer scientist in the Center of Applied Computing at LLNL, the team was awarded limited access to Frontier under the DOE's Advanced Scientific...

UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19

June 30, 2022 - 
Students from the University of California, Merced worked with mentors at LLNL to identify drug compounds that could be used to treat COVID-19 during a two-week Data Science Challenge (DSC) that concluded on June 6. For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced...

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

June 7, 2022 - 
The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

Kevin McLoughlin applies computational biology to complex problems

May 17, 2022 - 
Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Accelerating the path to precision medicine

March 22, 2022 - 
LLNL joined the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) consortium in 2018. The national, multiyear, multidisciplinary effort, led by the University of California at San Francisco in collaboration with Lawrence Berkeley and Argonne national laboratories and other leading research organizations and universities, combines neuroimaging, blood-based...

Machine learning model finds COVID-19 risks for cancer patients

March 10, 2022 - 
A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

Winter hackathon meets WiDS datathon

March 9, 2022 - 
Sponsored by the DSI, LLNL’s winter hackathon took place on February 16–17. Hackathons are 24-hour events that encourage collaborative programming and creative problem solving. In addition to traditional hacking, the hackathon included a special datathon competition in anticipation of the Women in Data Science (WiDS) conference on March 7. Hackathon and datathon participants presented their...

LLNL team models COVID-19 disease progression and identifies risk factors

Feb. 15, 2022 - 
An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...